This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceuticalcompanies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. Read
ACG Engineering, a division of ACG specialising in manufacturing solutions for the global pharmaceutical and nutraceutical industries, introduced its new ADAPT X feeder at CPhI & PMEC India 2024 in Delhi. Launching ADAPT X at PMEC 2024 allows us to demonstrate the transformative impact of this feeder to industry leaders,” he added.
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceuticalcompanies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration.
Eli Lilly raised its full-year guidance on Tuesday while it reported strong first-quarter sales of Zepbound, even as the pharmaceuticalcompany struggles to make enough of the obesity drug to meet the enormous demand. Lilly increased its adjusted earnings guidance for 2024 to a range of $13.50 per share, beating the $2.39
Following two decades of sharp increases for consumers, the companies vowed to cut insulin prices for some insulins by at least 70%, meaning many people could see their insulin costs capped at $35 a month in the near future. Sanofi and NovoNordisk will lower their prices as of January 2024; Lilly reduced it to $35 per month in March 2023.)
The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceuticalcompanies. Continue to STAT+ to read the full story…
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceuticalcompanies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You
A 2024 analysis of drugs included in this program showed they had 23% shorter clinical development timelines than those that were not part of the program, with no negative effects on their safety profiles.
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceuticalcompanies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You
Organisation of Pharmaceutical Producers of India (OPPI) in partnership with BCG has released a new report, titled “Winning in Indian Healthcare”. Global pharmaceuticalcompanies have played a pivotal role in transforming the healthcare sector in India.
Ever-increasing drug discovery and development timelines are a multiscale issue causing delays in patient access to medicines and increasing costs for pharmaceuticalcompanies. Edits made by EP News Bureau The post Digital transformation can accelerate drug development and discovery process appeared first on Express Pharma.
Alembic Pharmaceuticals announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Brexpiprazole Tablets, 0.25 mg, 1 mg, 2 mg, 3 mg and 4 mg, of Otsuka PharmaceuticalCompany, Ltd. mg, 1 mg, 2 mg, 3 mg and 4 mg. Brexpiprazole Tablets, 0.25
The event brought together over 330 professionals from across the industry’s value chain Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. The post PHARMAP 2024 held in Amsterdam, marks its fourth edition appeared first on Express Pharma.
“The Union Budget 2024-25, presented by FM Nirmala Sitharaman, marks a significant milestone as the first budget of the re-elected BJP-led NDA government. Simplifying regulatory processes and reducing these hurdles will create a more conducive environment for pharmaceuticalcompanies to operate, innovate, and expand.
… Biopharma layoffs have been higher over the past couple of years than during the industry’s boom times amid the Covid-19 pandemic, and job cuts this year have mainly hit larger pharmaceuticalcompanies to a greater degree than in the past , according to STAT.
Get insights into Michael Petroutsas' interview at ASCO 2024 discussing Astellas and their innovative advancements in the field. Learn more about the latest developments from this leading pharmaceuticalcompany.
Improving productivity is also vital as it aligns with the broader trend of AI adoption across industries, which is also pushing pharmaceuticalcompanies to integrate advanced technologies to remain competitive and keep up with digitalisation trends.
Danish pharmaceuticalcompany Novo Nordisk has announced that it will cut its prices for insulin products by up to 75%, beginning in January 2024. The price of Novolog and Novolog Mix 70/30 will be cut by 75%, with Novolin and Levemir seeing a 65% reduction in price.
In Q1 2024 alone, biopharmaceutical M&A reached a total deal value of $43.5 billion, with a 71 per cent year-on-year (YoY) increase of mega deals that were valued at $1 billion or more compared to Q1 2023, reveals GlobalData, a leading data and analytics company. billion increase in total deal value seen from 2022 to 2023.
The curtains have risen on DCAT 2024 in the vibran heart of New York City, and leading pharmaceuticalcompanies from around the world have converged for a week of innovation, collaboration, and strategic dialogue.
vriddhi 2024, Indian Drug Manufacturers’ Association (IDMA) 62nd Annual day celebrations, was organised on February 23-24, 2024 at FLAME University, the philanthropic venture of ENAM holdings in Pune, in partnership with Bain & Company.
This would encourage pharmaceuticalcompanies to enhance their R&D efforts, bolstering India’s status as a global leader in innovative healthcare solutions. ” Dr Harshit Jain, Founder & Global CEO, Doceree: “Budget 2024 is a defining moment for the pharmaceutical sector in India.
At its February 2024 meeting, the EMA’s human medicines committee (CHMP) recommended the extension of marketing authorisations for six treatments, and positive opinions for the approval of ten medicines. CHMP meeting highlights: January 2024 The post CHMP meeting highlights: February 2024 appeared first on European Pharmaceutical Review.
On December 13, 2024, Lupin, a global pharmaceuticalcompany, announced the acquisition of anti-diabetes trademarks GIBTULIO, GIBTULIO MET, and AJADUO from Boehringer Ingelheim International GmbH. The move is aimed at strengthening Lupins diabetes portfolio in India.
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.
The All India Pharmaceutical Associations Consortium (AIPAC) launched its first programme for Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical sector on 12 December 2024. Teachers and postgraduate and PhD students specialising in Pharmaceutics and Pharmaceutical Analysis also participated.
Ind-Ra has maintained a Stable rating Outlook on 67 per cent of its rated pharmaceuticalcompanies in FY25, citing a low leverage ratio and adequate liquidity, and expects limited rating movements in the sector. Most large pharmaceuticalcompanies rated by Ind-Ra fall into high investment-grade categories.
Recognising the pharmaceutical industry’s substantial contribution to India’s exports, we eagerly anticipate schemes that provide fiscal incentives to encourage such exports. 5) A revision of the GST on Active Pharmaceutical Ingredients can significantly reduce production costs.
In June 2024, the pharma and healthcare industry reported 76 deals worth $5B, compared to the last 12-month (June 2023 to May 2024) average of 95 deals worth $19B. Shanghai Fosun Pharmaceutical to acquire the remaining stake in Shanghai Henlius Biotech, a biopharmaceutical company, for a consideration of approximately $692.5
UCPMP 2024 Quiz Take part in this quiz to explore and learn more about the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024. UCPMP 2024 Quiz The number of attempts remaining is 2 1 / 15 What is the appropriate way to use healthcare professional endorsements in drug promotions? How to Participate?
On December 29, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 12 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on Complaints and Product Recall. The session provided clarity on the guidelines and cleared the queries of the pharma professionals.
Additionally, pharmaceuticalcompanies have increasingly turned to FDCs as a way to differentiate their products in a highly competitive market. By introducing unique formulations that combine existing drugs, companies can extend product life cycles and maintain exclusivity over certain combinations.
Wanbury, a pharmaceuticalcompany having a presence in API global market and domestic branded formulation has announced the successful completion of the United States Food & Drug Administration (USFDA) inspection at Patalganga site, Maharashtra.
He then explains three ways that specialty pharmaceuticalcompanies can use digital intake strategies to speed patient enrollment. To learn about AssistRx’s digital intake solutions, download Digital Intake for Specialty Drug Programs: Q1 2024 Progress Report. Read on for Adam’s insights.
French pharmaceuticalcompany Sanofi has announced that it will cut the list price of its Lantus (insulin glargine injection) 100 units/ml by 78%, beginning January 2024. read more
ASCO 2024, a pivotal conference for unveiling the latest advancements in cancer care, is just around the corner and oncologists are ready for it. Attendance Outlook: An impressive 72% of oncologists, whether attending in-person or virtually, are gearing up for ASCO 2024, underscoring the event’s importance in the oncology community.
Alkem Laboratories, an Indian pharmaceuticalcompany, has announced two strategic acquisitions aimed at strengthening its position in the domestic market. The company has signed a binding term sheet to acquire a 100 per cent stake in Adroit Biomed, a company focused on the skincare segment, for approximately INR 140 crore.
The impact of packaging is felt only when it does not do its job and therefore pharmaceuticalcompanies have traditionally invested quite a bit on product packs, also using them as part of their branding strategy. per cent CAGR.
As scientific and pharmaceuticalcompanies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. Summary of visa costs analysis 2024. How do the UKs immigration costs compare? References 1.
percent between 2024 and 2032. An increasing trend of outsourcing boosts growth of the market as pharmaceuticalcompanies are utilising advanced testing capabilities and optimising their drug development processes. percent market share between 2024 and 2032, based on the forecast by Straits Research. billion by 2032.
Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceuticalcompany. This data was presented at the 2024 American Society of Psychopharmacology Annual Meeting (Poster W80). At week 4, 22.5
The pharmaceutical industry is under pressure to ensure that vital health products are accessible to all, regardless of geographic location or socioeconomic status. The analysis found 42 unique approaches to measuring patient reach across these companies, with some companies using more comprehensive methods than others.
Drivers of global health impact in 2024 Reflecting on 2023 to inform change in the New Year Hindsight is a gift, as the saying goes, and as we close out the year, it is easy to see that 2023 was pivotal for global health. Agency for International Development.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content